Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Pharvaris NV expected to post a loss of 63 cents a share - Earnings Preview

* Pharvaris NV  PHVS.OQ   PHVS.O  is expected to show no
change in
quarterly revenue when it reports  results on November 14
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Pharvaris NV is for
a
loss of 63 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pharvaris
NV is
$18​, above​ its last closing price of $3.05. ​​​

Previous quarterly performance (using preferred earnings measure
in euros). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.57       -0.56      -0.38     Beat    31.8
 Mar. 31 2022  -0.43       -0.49      -0.48     Beat    2.7
 Dec. 31 2021  -0.99       -0.71      -0.09     Beat    87.3​
 Sep. 30 2021  -0.44       -0.42      -0.39     Beat    7.1
 ​​Jun.        -0.39       -0.39      -0.94     Missed  -141
 30 2021                                                
 Mar. 31 2021  -0.34       -0.34      -0.66     Missed  -95.6​
 Dec. 31 2020  -1.14       -1.19      -2.18     Missed  -83.2
 This summary was machine generated November 11 at 12:21 GMT. 
All figures in euros  unless otherwise stated

Recent news on Pharvaris NV

See all news